(XOM) Exxon Mobil - Ratings and Ratios
Crude Oil, Natural Gas, Fuels, Petrochemicals, Lubricants
Dividends
| Dividend Yield | 3.43% |
| Yield on Cost 5y | 11.97% |
| Yield CAGR 5y | 2.49% |
| Payout Consistency | 87.2% |
| Payout Ratio | 58.1% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 20.4% |
| Value at Risk 5%th | 34.9% |
| Relative Tail Risk | 3.65% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.18 |
| Alpha | -7.02 |
| CAGR/Max DD | 0.41 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.482 |
| Beta | 0.512 |
| Beta Downside | 0.840 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.92% |
| Mean DD | 7.74% |
| Median DD | 7.48% |
Description: XOM Exxon Mobil December 01, 2025
Exxon Mobil (XOM) operates an integrated oil-and-gas value chain across the United States, Guyana, Canada, the United Kingdom, Singapore, France and other international locations. Its business is split into four segments: Upstream (exploration and production of crude oil and natural gas), Energy Products (fuels, aromatics, catalysts and licensing), Chemical Products (olefins, polyolefins and intermediates) and Specialty Products (lubricants, basestocks, waxes, synthetics, elastomers and resins). The company also pursues lower-emission opportunities such as carbon capture, hydrogen, low-carbon fuels, Proxxima systems, carbon materials and lithium.
Key recent metrics underscore Exxon Mobil’s scale and financial strength: in 2023 the firm produced roughly 4.1 million barrels of oil-equivalent per day, generated ≈ $30 billion of free cash flow, and returned a 3.8 % dividend yield to shareholders while allocating about $20 billion to capital expenditures, including $2 billion earmarked for low-carbon projects.
Sector-level drivers that will shape XOM’s outlook include OPEC+ production decisions, global crude price volatility, rising demand for petrochemical feedstocks in Asia, and accelerating regulatory pressure to decarbonize energy supplies. Understanding how these forces intersect with Exxon’s diversified portfolio is essential for a realistic valuation.
For a deeper, data-driven valuation of XOM’s exposure to these trends, the ValueRay platform offers granular metrics worth exploring.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (29.95b TTM) > 0 and > 6% of Revenue (6% = 19.50b TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -1.86pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 3.28% (prev 7.17%; Δ -3.89pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 51.52b > Net Income 29.95b (YES >=105%, WARN >=100%) |
| Net Debt (53.27b) to EBITDA (68.77b) ratio: 0.77 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.14 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (4.33b) change vs 12m ago -2.94% (target <= -2.0% for YES) |
| Gross Margin 22.27% (prev 22.71%; Δ -0.44pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 70.92% (prev 73.58%; Δ -2.66pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 44.80 (EBITDA TTM 68.77b / Interest Expense TTM 980.0m) >= 6 (WARN >= 3) |
Altman Z'' 7.15
| (A) 0.02 = (Total Current Assets 88.50b - Total Current Liabilities 77.85b) / Total Assets 454.34b |
| (B) 1.06 = Retained Earnings (Balance) 480.37b / Total Assets 454.34b |
| warn (B) unusual magnitude: 1.06 — check mapping/units |
| (C) 0.10 = EBIT TTM 43.90b / Avg Total Assets 458.13b |
| (D) 2.76 = Book Value of Equity 514.39b / Total Liabilities 186.12b |
| Total Rating: 7.15 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 57.58
| 1. Piotroski 6.0pt |
| 2. FCF Yield 4.38% |
| 3. FCF Margin 7.32% |
| 4. Debt/Equity 0.26 |
| 5. Debt/Ebitda 0.77 |
| 6. ROIC - WACC (= 3.39)% |
| 7. RoE 11.42% |
| 8. Rev. Trend -49.12% |
| 9. EPS Trend -69.28% |
What is the price of XOM shares?
Over the past week, the price has changed by +0.53%, over one month by +3.41%, over three months by +7.63% and over the past year by +5.26%.
Is XOM a buy, sell or hold?
- Strong Buy: 10
- Buy: 7
- Hold: 10
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the XOM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 128.7 | 10.5% |
| Analysts Target Price | 128.7 | 10.5% |
| ValueRay Target Price | 128 | 9.8% |
XOM Fundamental Data Overview November 29, 2025
P/E Trailing = 16.706
P/E Forward = 15.5763
P/S = 1.4998
P/B = 1.8575
P/EG = 2.6849
Beta = 0.378
Revenue TTM = 324.92b USD
EBIT TTM = 43.90b USD
EBITDA TTM = 68.77b USD
Long Term Debt = 32.80b USD (from longTermDebt, last fiscal year)
Short Term Debt = 9.21b USD (from shortTermDebt, last quarter)
Debt = 67.14b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 53.27b USD (from netDebt column, last quarter)
Enterprise Value = 542.57b USD (489.29b + Debt 67.14b - CCE 13.87b)
Interest Coverage Ratio = 44.80 (Ebit TTM 43.90b / Interest Expense TTM 980.0m)
FCF Yield = 4.38% (FCF TTM 23.77b / Enterprise Value 542.57b)
FCF Margin = 7.32% (FCF TTM 23.77b / Revenue TTM 324.92b)
Net Margin = 9.22% (Net Income TTM 29.95b / Revenue TTM 324.92b)
Gross Margin = 22.27% ((Revenue TTM 324.92b - Cost of Revenue TTM 252.56b) / Revenue TTM)
Gross Margin QoQ = 22.42% (prev 22.58%)
Tobins Q-Ratio = 1.19 (Enterprise Value 542.57b / Total Assets 454.34b)
Interest Expense / Debt = 0.31% (Interest Expense 207.0m / Debt 67.14b)
Taxrate = 28.94% (3.16b / 10.93b)
NOPAT = 31.20b (EBIT 43.90b * (1 - 28.94%))
Current Ratio = 1.14 (Total Current Assets 88.50b / Total Current Liabilities 77.85b)
Debt / Equity = 0.26 (Debt 67.14b / totalStockholderEquity, last quarter 260.56b)
Debt / EBITDA = 0.77 (Net Debt 53.27b / EBITDA 68.77b)
Debt / FCF = 2.24 (Net Debt 53.27b / FCF TTM 23.77b)
Total Stockholder Equity = 262.39b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.59% (Net Income 29.95b / Total Assets 454.34b)
RoE = 11.42% (Net Income TTM 29.95b / Total Stockholder Equity 262.39b)
RoCE = 14.87% (EBIT 43.90b / Capital Employed (Equity 262.39b + L.T.Debt 32.80b))
RoIC = 10.36% (NOPAT 31.20b / Invested Capital 301.11b)
WACC = 6.97% (E(489.29b)/V(556.44b) * Re(7.90%) + D(67.14b)/V(556.44b) * Rd(0.31%) * (1-Tc(0.29)))
Discount Rate = 7.90% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 33.33 | Cagr: 3.93%
[DCF Debug] Terminal Value 76.58% ; FCFE base≈27.38b ; Y1≈24.54b ; Y5≈20.93b
Fair Price DCF = 89.75 (DCF Value 378.47b / Shares Outstanding 4.22b; 5y FCF grow -12.80% → 3.0% )
EPS Correlation: -69.28 | EPS CAGR: -3.99% | SUE: -0.26 | # QB: 0
Revenue Correlation: -49.12 | Revenue CAGR: 0.66% | SUE: -0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.70 | Chg30d=-0.014 | Revisions Net=+2 | Analysts=16
EPS next Year (2026-12-31): EPS=7.45 | Chg30d=-0.076 | Revisions Net=+1 | Growth EPS=+7.0% | Growth Revenue=-0.2%
Additional Sources for XOM Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle